Gritstone Bio Can Tap $25M New DIP As It Works Toward Sale

By Alex Wittenberg · November 13, 2024, 4:27 PM EST

Vaccine developer Gritstone bio Inc. won a Delaware bankruptcy judge's approval Wednesday to borrow $25 million in new financing to support itself in Chapter 11 as the biotechnology company works to...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Case Information

Case Title

Gritstone bio, Inc.

Case Number

Court

Delaware

Nature of Suit

Date Filed

October 10, 2024

Recent Articles By Alex

November 12, 2024
Celsius Judge Rejects Pro Se Creditor's $206,000 Fee Bid
November 12, 2024
FTX Sues Binance, Former CEO Zhao Seeking $1.8B Clawback
November 01, 2024
Buca Di Beppo Gets OK On $27M Sale To Main Street Capital
October 30, 2024
Implant Maker Exactech Can Tap $85M DIP After Cutting Fees
October 29, 2024
MVP: Latham's George Davis
October 29, 2024
PE-Owned Implant Maker Plagued By Lawsuits Hits Ch. 11
October 28, 2024
Ex-Judge Can't Shield Bank Docs; Tupperware Agrees To Sale
October 25, 2024
Incora To Exit Ch. 11 With Uptier Fight Headed To Appeal
October 23, 2024
American Tire Hits Ch. 11 Again With $1.9B Of Debt, Sale Plan
October 21, 2024
Keeping Track Of The Catholic Diocese Bankruptcy Cases